RA Capital Management, L.P. 13D and 13G filings for Werewolf Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-14 5:23 pm Sale | 2026-05-12 | 13D | WEREWOLF THERAPEUTICS INC HOWL | RA Capital Management, L.P. | 6,116,140 12.600% | -565,167 (-8.46%) | Filing |
| 2025-11-06 4:29 pm Sale | 2025-11-04 | 13D | WEREWOLF THERAPEUTICS INC HOWL | RA Capital Management, L.P. | 6,681,307 13.800% | -65,500 (-0.97%) | Filing |
| 2025-05-14 6:09 pm Purchase | 2025-05-12 | 13D | WEREWOLF THERAPEUTICS INC HOWL | RA Capital Management, L.P. | 6,746,807 15.000% | 553,926 (+8.94%) | Filing |
| 2024-05-07 4:52 pm Purchase | 2024-05-03 | 13D | WEREWOLF THERAPEUTICS INC HOWL | RA Capital Management, L.P. | 6,192,881 14.200% | 13,846 (+0.22%) | Filing |
| 2024-02-14 5:17 pm Purchase | 2024-02-12 | 13D | WEREWOLF THERAPEUTICS INC HOWL | RA Capital Management, L.P. | 6,179,035 15.200% | 19,981 (+0.32%) | Filing |